Etzioni, Ruth <br/><br/>
Measures of survival benefit in cancer drug development and their limitations.  [electronic resource] 

 -  Urologic oncology  Mar 2015 
 - 122-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1873-2496 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2014.11.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Chemistry, Pharmaceutical--methods<br/>Disease-Free Survival<br/>Drug Design<br/>Humans<br/>Neoplasms--drug therapy<br/>Outcome Assessment, Health Care<br/>Proportional Hazards Models<br/>Randomized Controlled Trials as Topic<br/>Research Design